Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Passage Bio
Passage Bio
CEO Shakeups at BIO, Passage Bio and Palisade Bio
BioSpace
Fri, 10/14/22 - 10:23 am
BIO
Passage Bio
Palisade Bio
Maze Therapeutics
Cerecin
Pharma CEOs
Passage Bio CEO Bruce Goldsmith Abruptly Steps Down
BioSpace
Wed, 06/1/22 - 07:34 pm
Passage Bio
Bruce Goldsmith
Pharma CEOs
layoffs
'Stay alive': Wave of layoffs crashes into biotech startup inferno
Fierce Biotech
Mon, 03/28/22 - 10:38 am
biotech
layoffs
startups
Zosano Pharma
Ovid Therapeutics
Passage Bio
Athenex
Passage Bio to cut jobs in latest biotech restructuring
BioPharma Dive
Tue, 03/15/22 - 11:31 pm
Passage Bio
restructuring
gene therapy
layoffs
A high-profile gene therapy biotech takes aim at Huntington's
BioPharma Dive
Wed, 12/8/21 - 11:37 pm
Passage Bio
gene therapy
Huntington's disease
Approved! FDA Grants IND Clearance to Three More Candidates Today
BioSpace
Thu, 01/28/21 - 11:14 pm
FDA
IND clearance
COPD
Zofin
Organicell
COVID-19
Passage Bio
PBFT02
frontotemporal dementia
KemPharm
KP879
stimulant use disorder
FDA puts up a red light for Passage Bio’s first gene therapy program
Endpoints
Thu, 08/13/20 - 10:44 am
Passage Bio
gene therapy
FDA
Covid-19 stalls biotech flotations
EP Vantage
Fri, 04/10/20 - 10:26 am
COVID-19
IPOs
Revolution Medicines
Black Diamond Therapeutics
Passage Bio
Beam Therapeutics
Schrödinger
Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO
Endpoints
Fri, 02/28/20 - 10:37 am
Passage Bio
IPOs
gene therapy
Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO
Fierce Biotech
Mon, 09/23/19 - 10:43 am
gene therapy
Passage Bio
Janssen
Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B
Endpoints
Wed, 09/4/19 - 11:21 pm
gene therapy
Passage Bio
Access Biotechnology
More M&A Activity Expected Around AAV-Based Gene Therapies, Analyst Says
BioSpace
Wed, 08/7/19 - 11:34 pm
gene therapy
M&A
Audentes Therapeutics
Regenxbio
Passage Bio